Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells

The survival of patients diagnosed with glioblastoma (GBM), the most deadly form of brain cancer, is compromised by the proclivity for local invasion into the surrounding normal brain, which prevents complete surgical resection and contributes to therapeutic resistance. Tumor necrosis factor-like we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Roos, Alison, Dhruv, Harshil D., Mathews, Ian T., Inge, Landon J., Tuncali, Serdar, Hartman, Lauren K., Chow, Donald, Millard, Nghia, Yin, Holly H., Kloss, Jean, Loftus, Joseph C., Winkles, Jeffrey A., Berens, Michael E., Tran, Nhan L.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355340/
https://ncbi.nlm.nih.gov/pubmed/28103571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14685
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars